Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-004469
Filing Date
2024-02-20
Accepted
2024-02-20 18:36:11
Documents
1
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02202024_110257.html 4  
1 form4-02202024_110257.xml 4 14572
  Complete submission text file 0001415889-24-004469.txt   16151
Mailing Address 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746
Business Address
York Charles N II (Reporting) CIK: 0001655962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 24655595

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)